Compare Fiverr International Ltd (FVRR) vs Tango Therapeutics Inc. (TNGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fiverr International Ltd vs Tango Therapeutics Inc. — how do they compare? Fiverr International Ltd trades at $8.56 (market cap $309.18M), while Tango Therapeutics Inc. trades at $22.5 (market cap $3.75B). The key difference: Tango Therapeutics Inc. is far larger — about 12.1× Fiverr International Ltd's market cap, and Tango Therapeutics Inc. is trading nearer its 52-week high, Fiverr International Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fiverr International Ltd for 62 Days and Tango Therapeutics Inc. for 0 Days on average.
| FVRR | TNGX | |
|---|---|---|
Market Cap | $309.18M | $3.75B |
Volume | 481,205 | 9,619,106 |
Sector | Media | Health |
52-Week High | $23.60 | $32.90 |
52-Week Low | $8.47 | $7.50 |
Typical Hold Time | 62 Days | 0 Days |
Enterprise Value | $61.56M | $2.77B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fiverr International (FVRR) trades at $8.55, down 0.81% with bearish technical signals despite attractive valuation metrics including a P/E of 10.62 and P/S of 0.75. Recent Q2 2026 earnings missed expectations with revenue declining 10% year-over-year as AI disruption pressures freelance demand. The company maintains strong gross margins of 82% but faces headwinds from accelerating AI adoption compressing lower-value freelance work.
While valuation appears compelling with consensus price target of $10.50 representing 23% upside, near-term risks from AI disruption and recent earnings misses warrant caution. Analyst sentiment leans neutral with 76% hold ratings, reflecting uncertainty around growth trajectory amid structural industry shifts. Cash flow trends show volatility with negative net cash flow projected for 2026.
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Fiverr International Ltd
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →
